Xbrane Biopharma to Present and Host 1×1 meetings at the LSX Nordic Congress

English

News

PR

Xbrane Biopharma AB (publ), today announce that its CEO, Martin Åmark, will be presenting at the LSX Nordic Leadership and Investment Congress in Stockholm on 29 August 2019 at 13:45 at Nasdaq Stockholm, Tullvaktsvägen 15.

Martin Åmark, Xbrane’s CEO, will be representing the company and hosting one-on-one meetings during the conference. To schedule a meeting please contact the LSX Nordic Congress organizers or Martin Åmark.

Contacts

Martin Åmark, CEO/IR
M: +46 (0) 763-093 777
E: martin.amark@xbrane.com

Susanna Helgesen, CFO
M: +46 (0) 708-278 636
E: susanna.helgesen@xbrane.com

About Us

Xbrane is a commercial phase Swedish biopharmaceutical company specialized in biosimilars. Xbrane has a patented protein production platform for development of biosimilars and world leading expertise in biosimilars. Xbrane’s headquarter is located in Solna outside of Stockholm and the company’s in-house research and development facilities are in Sweden and Italy. Xbrane is listed at Nasdaq First North since February 3rd, 2016 under the name XBRANE and Avanza Bank AB is Xbrane’s certified adviser (corp@avanza.se, +46 (0)8 409 421 20).
For more information see www.xbrane.com.

Attachments

Xbrane Biopharma to Present and Host 1×1 meetings at the LSX Nordic Congress